Stock Activity: Citigroup Inc., Galapagos NV (NASDAQ:GLPG), Micron Technology (NASDAQ:MU), Insulet Corporation (NASDAQ:PODD), WAVE Life Sciences Pte. (NASDAQ:WVE)

Citigroup Inc. (NYSE:C) ended the last trading day at $51.21. Company weekly volatility is calculated as 2.67% and price to cash ratio as 0.27. Citigroup Inc. (NYSE:C) showed a weekly performance of 0.20%.

Citigroup Inc. (NYSE:C) said that, it plans to cut at least 2,000 jobs starting next month as Chief Executive Officer Michael Corbat restructures some of the bank’s businesses.

On 18 December, Galapagos NV (NASDAQ:GLPG) shares increased 1.67% and was closed at $57.11. Galapagos NV (NASDAQ:GLPG) year to date (YTD) performance is 32.81%.

Galapagos NV (NASDAQ:GLPG) and Gilead Sciences, Inc. (NASDAQ: GILD) announced a collaboration into a global partnership for developing and commercializing Filgotinib – JAK1-selective inhibitor, for the treatment of inflammatory conditions. Initiation of the mutual global development will start with Phase III trials in 2016.

Micron Technology, Inc. (NASDAQ:MU) shares increased 0.28% in last trading session and ended the day at $14.36. MU Gross Margin is 32.20% and its has a return on assets of 12.10%. Micron Technology, Inc. (NASDAQ:MU) quarterly performance is -8.83%.

On 7 December, Micron Technology, Inc. (NASDAQ:MU) said that, it is closing a manufacturing facility in Puerto Rico and moving the work to China. Around 185 jobs are affected by the closure, which is due to be completed by the end of this month, according to a U.S. government filing.

Insulet Corporation (NASDAQ:PODD) caters to the Healthcare space. It has a net profit margin of -17.40% and weekly performance is -0.33%. On the last day of trading company shares ended up at $36.17. Insulet Corporation (NASDAQ:PODD) distance from 50-day simple moving average (SMA50) is 6.39%.

On 11 December, Insulet Corporation (NASDAQ:PODD) said that, it is notifying consumers and health care professionals about a slight increase in reports in which the OmniPod’s needle mechanism to deliver insulin fails to deploy or is delayed.

WAVE Life Sciences Pte. Ltd. (NASDAQ:WVE) caters to the Healthcare space. Its weekly performance is 11.09%. On the last day of trading company shares ended up at $15.32. WAVE Life Sciences Pte. Ltd. (NASDAQ:WVE) distance from 50-day simple moving average (SMA50) is 6.64%.

Stock analysts at Leerink Swann started coverage on shares of WAVE Life Sciences Pte. Ltd. (NASDAQ:WVE) in a research note issued to investors on Monday, The Flyreports. The brokerage set an “outperform” rating on the stock.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *